Artificial Hair: From the Dawn to Automatic Biofibre Hair Implant

The 2017 review article discussed the development of Biofibre® hair implants as a solution for alopecia, highlighting the evolution from early artificial hair implants that led to complications and an FDA ban in 1983, to the approval of biocompatible Biofibre® implants in the 1990s by the European Union. The article emphasized the importance of proper patient selection, adherence to medical protocols, and aftercare to minimize complications. An automatic Biofibre® hair implant device was noted for providing immediate aesthetic results, particularly for patients with diffuse alopecia or hair thinning. A clinical study involving 133 patients (95 men and 38 women) over three years showed a high satisfaction rate of 96.2%, with fiber loss not exceeding 10% per year in 91.4% of cases. Histological studies confirmed the biocompatibility of the fibers, and the technique was deemed safe and effective when proper procedures were followed, with the ability to remove implants without scarring. The implants were suitable for various types of alopecia, but not recommended for individuals with certain medical conditions or those working in dirty environments.